Pendal Group LTD United Therapeutics Corp Transaction History

Pendal Group LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$76.06 - $120.81 $2.87 Million - $4.56 Million	-37,728 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$107.15 - $126.84 $435,886 - $515,985	-4,068 Reduced 9.73%	37,728 $0
Q4 2018 Jan 30, 2019	SELL	$101.4 - $128.73 $314,441 - $399,191	-3,101 Reduced 6.91%	41,796 $4.55 Million
Q3 2018 Nov 05, 2018	SELL	$113.81 - $129.46 $372,386 - $423,593	-3,272 Reduced 6.79%	44,897 $0
Q1 2018 May 08, 2018	SELL	$107.21 - $151.94 $868,079 - $1.23 Million	-8,097 Reduced 14.39%	48,169 $0
Q4 2017 Feb 06, 2018	SELL	$118.58 - $151.28 $490,565 - $625,845	-4,137 Reduced 6.85%	56,266 $0
Q3 2017 Nov 01, 2017	SELL	$114.6 - $136.81 $1.1 Million - $1.31 Million	-9,564 Reduced 13.67%	60,403 $0
Q2 2017 Aug 11, 2017	BUY	N/A	69,967	69,967 $0

717

41.1M

123K

100K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $13.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

Stay updated on Pendal Group LTD with notifications on news.